Patent · US Expired

2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

US7407958B2 · kind B2 · utility

5Cited by
3References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 8, 2004
Grant dateAug 5, 2008
Priority date—
Expiry dateNov 9, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula:wherein R1, R2, R3, A1 and A2 are as defined herein, which are used advantageously in inhibiting the TGF-β and/or activin signaling pathway in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.